CMPS News and Press, COMPASS Pathways Plc From 01/31/24

LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fireside chat at the Oppenheimer 34th Annual Healthcare Life S...

The European Union (EU) is funding research into psychedelic-based therapies for patients with incurable diseases. Researchers will use EU funding to determine if psychedelic drugs such as psilocybin can help alleviate psychologic distress in palliative-care patients. While palliative and e...

2024-01-24 09:00:41 ET Palm Beach, FL – January 24, 2024 – FN Media Group News Commentary – The coming years could see a massive shift in the U.S. government’s approach to regulating hallucinogenic drugs. Several biopharma companies are developing psy...

2024-01-23 17:06:11 ET Gainers: Zoomcar Holdings ( ZCAR ) +8% . Netflix ( NFLX ) +7% . Cricut ( CRCT ) +5% . Tenaya Therapeutics ( TNYA ) +5% . ARS Pharmaceuticals ( SPRY ) +4% . Losers: Humacyte ( HUMA ) -5% . ...

Researchers recently used an artificial intelligence (AI) tool developed by London-based artificial intelligence research laboratory Deepmind Technologies Limited to identify thousands of potential psychedelic proteins. Called AlphaFold , the artificial intelligence protein-structure predictio...

In the last couple of years, ketamine has been used to treat depression , with ketamine clinics across Canada and the United States administering the drug for the management of anxiety, depression and post-traumatic stress disorder. Ketamine is a dissociative drug commonly used as an anesthe...

LONDON, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Hackensack Meridian Health (“HMH”), a leading not-for-prof...

Researchers from Montclair State University recently dived into multitudes of social media posts to try and understand how psilocybin, the main psychedelic element within magic mushrooms, affects an individual’s self-perception . Published in the “ Journal of Psychedelic Studies ,&...

2024-01-09 12:00:00 ET Summary Critical catalysts are approaching in the psychedelic sector, with the potential for the first FDA-approved psychedelic therapy by the end of the year. Alex Carchidi shares why Compass Pathways, Cybin, and Atai are the most promising companies for in...

LONDON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, and Greenbrook TMS Inc. (NASDAQ: GBNH) (“Greenbrook TMS”), a ...